Description
Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the topoisomerase I inhibitor deruxtecan (a derivative of exatecan). It is licensed for the treatment of breast cancer or gastric or gastroesophageal adenocarcinoma.
It was approved for medical use in the United States in December 2019, in Japan in March 2020, in the European Union in January 2021, and in Australia in October 2021.
Trastuzumab deruxtecan is the first approved therapy by the US Food and Drug Administration (FDA) targeted to people with the HER2-low breast cancer subtype subset of HER2-negative breast cancer.
How to buy ENHERTU (trastuzumab deruxtecan) in India or Globally?
Buy ENHERTU (trastuzumab deruxtecan) directly from Aark Pharmaceuticals at discounted pricing.
Aark Pharmaceuticals, A Leading ISO. 9001.2008 approved C&F, distributors, stockiest & retailer of anti-cancer, anti-HIV, life-saving medicines and medical and surgical devices. Our organization is customer-oriented and strongly believes in the quality and timely supply of superior medicines at an economical rate.
What is the best price of ENHERTU (trastuzumab deruxtecan)?
Please contact us at +91 9999156233 or you can drop an email to us at sales@aarkpharma.com.